Table 2 Characteristics of the study population according to delay entry status
Characteristics | Total (N = 223) n(%) or mean ± SD | Delayed (N = 50) n(%) or mean ± SD | Not delayed (N = 173) n(%) or mean ± SD | p-value |
|---|---|---|---|---|
Age | 33.3 ± 9.3 | 33.4 ± 11.3 | 33.3 ± 8.7 | 0.10 |
Gender | ||||
Male | 83 (37.2) | 19 (38.0) | 64 (36.9) | 0.10 |
Female | 140 (62.8) | 31 (62.0) | 109 (63.1) | |
Result shared | 178(79.8) | 30(60.0) | 148 (85.5) | 0.92 |
Alcohol | 121 (54.3) | 34 (68.0) | 87 (50.3) | 0.04 |
WHO HIV stage | ||||
WHO I | 125 (56.1) | 20 (40.0) | 105 (61.0) | <0.001 |
WHO II | 38 (17.0) | 17 (34.0) | 21 (12.0) | |
WHO III | 54 (25.2) | 10 (20.0) | 44 (25.0) | |
WHO IV | 06 (2) | 3 (6.0) | 04 (2.0) | |
Fever >1 month | 35 (15.7) | 5 (10.0) | 30 (17.3) | 0.010 |
Weight loss > 10 % | 47 (21.1) | 23 (13.3) | 24 (48.0) | <0.001 |
CD4 count | 441.4 ± 279.3 | 458.2 ± 281.7 | 384.7 ± 266.2 | 0.01 |
Travel hours to TC | 0.7 ± 1.4 | 0.7 ± 1.5 | 0.3 ± 0.6 | 0.082 |